A SOLUTION FOR MITRAL VALVE DISEASE
Novel gene therapies for dogs
Because your dog deserves to live its best life
Novel gene therapies for dogs
Because your dog deserves to live its best life
Location: United States
Phone: +1 858-381-3462
Total raised: $10M
Investors 6
| Date | Name | Website |
| - | VCapital | vcapital.c... |
| - | KdT Ventur... | kdtvc.com |
| - | Digitalis ... | digitalisv... |
| - | Wealthing ... | wealthing.... |
| - | Companion ... | companionf... |
| 25.10.2023 | Diamond Bi... | diamondbio... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 12.06.2026 | - | $6M | VCapital |
| 02.07.2024 | - | $4M | - |
Mentions in press and media 14
| Date | Title | Description |
| 29.08.2026 | Bryan Johnson tackled human longevity. Now he wants dogs to live forever. | Tech entrepreneur Bryan Johnson has become famous for his mission to help humans live forever, with his catchphrase "Don't die." Now he wants to do the same thing for dogs. Johnson's interest in canine longevity was piqued when he... |
| 18.06.2026 | Jetstream Venture Fund Invests In Rejuvenate Bio Alongside Merck | Jetstream Venture Fund announced that it has established an investment interest in Rejuvenate Bio, a biotechnology company focused on gene therapy-based treatments for chronic and age-related diseases. The investment gives Jetstream exposur... |
| 15.06.2026 | Rejuvenate Bio Accelerates Gene Therapy with $6M Funding, Merck Partnership | Rejuvenate Bio, a San Diego biotechnology innovator, secured $6 million in vital financing. This capital propels its pioneering gene therapy platform. The company targets age-related and chronic diseases. Focus areas include companion anima... |
| 12.06.2026 | Rejuvenate Bio Closes $6 Million Financing And Strategic R&D Collaboration With Merck Animal Health | Lifespan Vision Ventures announced that its portfolio company, Rejuvenate Bio, has completed a $6 million financing round and entered into a strategic research and development collaboration with Merck Animal Health, marking a key milestone ... |
| 11.06.2026 | Lifespan Portfolio Company Rejuvenate Bio Closes $6 Million Financing and R&D Collaboration with Merck Animal Health | Milestone financing and R&D collaboration advances gene therapy programs targeting chronic and age-related diseases in companion animals. NORWALK, Conn., June 11, 2026 /PRNewswire/ -- Lifespan Vision Ventures (LVV), an investment firm f... |
| 09.06.2026 | Rejuvenate Bio Raises $6 Million And Partners With Merck Animal Health To Advance Gene Therapy Programs | Rejuvenate Bio, a biotechnology company focused on developing gene therapies for chronic and age-related diseases, announced the closing of a $6 million financing round led by VCapital. Additional participants in the round include Merck Ani... |
| 08.06.2026 | Rejuvenate Bio Raises $6M in Financing | Rejuvenate Bio, a San Diego, CA-based biotechnology company developing gene therapies for age-related and chronic diseases, raised $6M in funding. The round was ed by VCapital, with participation from Merck Animal Health, Kendall Capital Pa... |
| 08.06.2026 | Rejuvenate Bio Announces $6 Million Financing | SAN DIEGO, CA, Rejuvenate Bio, a biotechnology company developing gene therapies for age-related and chronic diseases, announced the closing of a $6 million financing round led by VCapital. >> Click here for more funding data on Reju... |
| 02.07.2024 | Rejuvenate Bio Receives $4M in Funding | Rejuvenate Bio, a San Diego, CA-based biotechnology company dedicated to developing novel gene therapies for chronic age-related diseases, received $4M in grant from California Institute for Regenerative Medicine (CIRM). The company intends... |
| 10.03.2023 | Tweekly. Выпуск 160. Бессмертие как сервис | Что сейчас растёт и как это применить 1. Бессмертие как сервис (IaaS). То, чего все хотят и боятся одновременно. 2. Цифровые клоны городов и производств — быстрая проверка «капиталоемких» гипотез. Следующий шаг - проверка жизнеспособности п... |
Show more